Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.
作者信息
Hudhud Dania, Caldera Freddy, Cross Raymond K
机构信息
University of Maryland School of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD, USA.
Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
出版信息
Inflamm Bowel Dis. 2022 Mar 2;28(3):492-493. doi: 10.1093/ibd/izab241.
Abstract
摘要
相似文献
1
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD.解决炎症性肠病患者对新冠疫苗的犹豫态度。
Inflamm Bowel Dis. 2022 Mar 2;28(3):492-493. doi: 10.1093/ibd/izab241.
2
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease.误解导致炎症性肠病患者对 COVID-19 疫苗犹豫不决。
Can J Gastroenterol Hepatol. 2022 Sep 10;2022:4527844. doi: 10.1155/2022/4527844. eCollection 2022.
3
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association.炎症性肠病患者对COVID-19疫苗的接种意愿与犹豫态度：意大利炎症性肠病患者协会全国调查中的决定因素分析
Inflamm Bowel Dis. 2022 Mar 2;28(3):474-478. doi: 10.1093/ibd/izab172.
4
COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety.COVID-19 疫苗犹豫：疫苗安全性的错误信息和认知。
Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504. doi: 10.1080/21645515.2021.1950504. Epub 2021 Jul 30.
5
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
6
COVID-19 Vaccine Hesitancy in Patients with Inflammatory Bowel Disease.COVID-19 疫苗犹豫在炎症性肠病患者中。
Dig Dis Sci. 2022 Oct;67(10):4671-4677. doi: 10.1007/s10620-021-07377-5. Epub 2022 Jan 29.
7
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.SARS-CoV-2 疫苗接种在炎症性肠病中的应用：过去的经验教训、当前的证据和未来的挑战。
J Crohns Colitis. 2021 Aug 2;15(8):1376-1386. doi: 10.1093/ecco-jcc/jjab046.
8
Letter of Reply to "Response to: COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients' Association".致《对〈炎症性肠病患者的新冠疫苗接种意愿与犹豫：意大利炎症性肠病患者协会全国调查中的决定因素分析〉的回应》的回复信
Inflamm Bowel Dis. 2022 Mar 30;28(4):e57-e58. doi: 10.1093/ibd/izab281.
9
Addressing Vaccine Hesitancy to Reduce Racial and Ethnic Disparities in COVID-19 Vaccination Uptake Across the UK and US.应对疫苗犹豫以减少英国和美国新冠疫苗接种率方面的种族和族裔差异。
Front Public Health. 2021 Dec 7;9:789753. doi: 10.3389/fpubh.2021.789753. eCollection 2021.
10
Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.抗 SARS-CoV-2 疫苗在炎症性肠病患者中的实施情况和短期不良事件：一项国际网络调查。
J Crohns Colitis. 2022 Aug 4;16(7):1070-1078. doi: 10.1093/ecco-jcc/jjac010.
引用本文的文献
1
Unreliable information and fear: Barriers to vaccination among IBD patients in China.不可靠信息与恐惧：中国炎症性肠病患者的疫苗接种障碍
Hum Vaccin Immunother. 2025 Dec;21(1):2446071. doi: 10.1080/21645515.2024.2446071. Epub 2025 Jan 24.
2
COVID-19 Vaccine Information Exposure: The Effect of Online Authority vs. Non-Authority Sources on Beliefs, Emotions and Information Engagement Behaviors.新冠疫苗信息曝光：线上权威与非权威来源对信念、情绪及信息参与行为的影响
Vaccines (Basel). 2024 Sep 26;12(10):1096. doi: 10.3390/vaccines12101096.
3
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.全球范围内胃肠病学家和医疗保健提供者在促进炎症性肠病患者 COVID-19 免疫接种中的作用：系统评价和荟萃分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16.
4
COVID-19 Vaccines for Adults and Children with Autoimmune Gut or Liver Disease.适用于患有自身免疫性肠道或肝脏疾病的成人和儿童的新冠疫苗。
Vaccines (Basel). 2022 Dec 5;10(12):2075. doi: 10.3390/vaccines10122075.
5
COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.炎症性肠病患者的新冠病毒疫苗接种：认知、疗效与安全性
Gastroenterol Hepatol (N Y). 2022 Jul;18(7):388-399.
6
COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study.英夫利昔单抗和维多珠单抗治疗的炎症性肠病患者对COVID-19疫苗加强针的接种意愿：一项横断面研究
Vaccines (Basel). 2022 Jul 22;10(8):1166. doi: 10.3390/vaccines10081166.
7
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD).炎症性肠病（IBD）中的COVID-19疫苗接种
J Clin Med. 2022 May 9;11(9):2676. doi: 10.3390/jcm11092676.
8
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease.2019冠状病毒病疫苗在炎症性肠病患者中的有效性和安全性
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):145-155.
Zotero 插件